At a glance
(thousands of €, if not stated otherwise) |
|
|
||||
|
||||||
Income statement |
31/03/2018 |
31/03/2017 |
||||
Revenues(1) |
37,907 |
33,992 |
||||
Other income |
6,931 |
5,871 |
||||
R&D expenditure |
(69,765) |
(44,930) |
||||
S, G&A expenses |
(7,110) |
(6,158) |
||||
Operating expenses |
(76,875) |
(51,088) |
||||
Operating loss |
(32,036) |
(11,225) |
||||
Net financial results |
(5,184) |
(2,380) |
||||
Taxes |
(62) |
– |
||||
Net loss |
(37,283) |
(13,605) |
||||
|
|
|
||||
Balance sheet |
31/03/2018 |
31/12/2017 |
||||
Cash and cash equivalents |
1,108,186 |
1,151,211 |
||||
R&D incentives receivables |
80,870 |
75,783 |
||||
Assets |
1,229,864 |
1,286,274 |
||||
Shareholders' equity(1) |
899,345 |
1,011,983 |
||||
Deferred income(1) |
268,654 |
219,892 |
||||
Other liabilities |
61,865 |
54,399 |
||||
|
|
|
||||
Cash flow |
31/03/2018 |
31/03/2017 |
||||
Operational cash burn(2) |
(41,335) |
(23,878) |
||||
Cash flow generated / used (–) in financing activities |
3,905 |
(14) |
||||
Effect of currency exchange rate fluctuation on cash and cash equivalents |
(5,595) |
(2,496) |
||||
Decrease in cash and cash equivalents |
(43,025) |
(19,856) |
||||
Cash and cash equivalents on 31 March |
1,108,186 |
953,385 |
||||
|
|
|
||||
Financial ratios |
31/03/2018 |
31/03/2017 |
||||
Number of shares issued on 31 March |
51,234,962 |
46,256,078 |
||||
Basic and diluted loss per share (in €) |
(0.73) |
(0.29) |
||||
Share price on 31 March (in €) |
81.30 |
81.58 |
||||
Total group employees on 31 March (number) |
634 |
530 |